Meeting
2021 ASCO Annual Meeting
A new option in pain prevention with bliss, a therapeutic virtual reality solution in bone marrow biopsy context: Results of a French open-label multicenter randomized phase II/III study (REVEH Trial).
Authors
Katell LE DU
Centre Jean Bernard-Clinique Victor Hugo, Institut Inter-Régional De Cancérologie, Le Mans, France
Katell LE DU , Anne-Lise Septans , Frédéric Maloisel , Hélène Vanquaethem , Anna Schmitt , Marielle Le Goff , Marie Pierre Moles , Marie Zinger , Hugues Pierre Bourgeois , Mélanie Peron , Fabrice Denis , Stéphane Bouchard
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Health Services Research and Quality Improvement
Track
Quality Care/Health Services Research
Sub Track
Quality Improvement
Clinical Trial Registration Number
03483194
Citation
J Clin Oncol 39, 2021 (suppl 15; abstr 6573)
DOI
10.1200/JCO.2021.39.15_suppl.6573
Abstract #
6573
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Effects of virtual reality on pain and anxiety in patients with cancer undergoing bone marrow biopsy.
First Author: Jacek K. Pinski
Poster
2020 ASCO Virtual Scientific Program
Head-to-head comparison of the non-G-CSF small molecule single agent (SA) plinabulin with SA pegfilgrastim for the prevention of docetaxel chemotherapy (chemo)-induced neutropenia (CIN) in the protective-1 trial.
First Author: Douglas W. Blayney
Poster
2024 ASCO Annual Meeting
Effect of cancer screening with multi-cancer early detection testing and whole body MRI on cancer worry in a high-risk population.
First Author: Dan Raz
First Author: Salah-Eddin Al-Batran